Open AccessIMMUNOGENICITY OF THE SEVEN VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN PATIENTS WITH ATAXIA-TELANGIECTASIA
Author(s) -
Ralf Schubert,
Janine Reichenbach,
Markus A. Rose,
Stefan Zielen
Publication year - 2004
Publication title -
the pediatric infectious disease journal/the pediatric infectious disease journal
Language(s) - English
Resource type - Journals
eISSN - 1532-0987
pISSN - 0891-3668
DOI - 10.1097/01.inf.0000115737.35353.55
Subject(s) - immunogenicity , medicine , pneumococcal conjugate vaccine , conjugate vaccine , pneumococcal disease , immunology , virology , ataxia telangiectasia , serotype , immunization , antibody , streptococcus pneumoniae , microbiology and biotechnology , biology , antibiotics , dna , genetics , dna damage
Immune responses to a 7-valent pneumococcal conjugate vaccine were determined in 10 patients with ataxia-telangiectasia who are at high risk for pneumococcal disease because of immunodeficiency. Pneumococcal antibody titers for 7 serotypes measured increased 2.0- to 7.5-fold after immunization.